Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
shuangshen huoxue tongluo granules
- Development stage
- Unknown
- Lead developer
- Chongqing Sainuo Biological Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Shuangshen Huoxue Tongluo Granules is a Traditional Chinese Medicine (TCM) product developed and manufactured by Chongqing Sainuo Biological Pharmaceutical. Formulated as oral granules, it is approved in China for the treatment of various cardiovascular and cerebrovascular conditions, including hyperlipidemia, hypertension, coronary heart disease, and ischemic cerebrovascular diseases such as stroke. The medication is designed to promote blood circulation, resolve blood stasis, and unblock the body's meridians (collaterals), thereby improving blood flow and managing lipid profiles in patients with chronic vascular conditions. As a TCM formulation, it typically utilizes a multi-component approach, often featuring herbal extracts like Salvia miltiorrhiza and Panax notoginseng to achieve its therapeutic effects.
- Brand names
- 双参活血通络颗粒
- Other names
- Shuangshen Huoxue Tongluo GranulesShuangshen Huoxue Tongluo Keli
Beyond the preview
Go deeper on shuangshen huoxue tongluo granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on shuangshen huoxue tongluo granules.